Changes to the Patented Medicine Prices Review Board (PMPRB) regime, contained in pending amendments to the Patented Medicines Regulations, have been delayed until July 1, 2022.
These amendments form the basis for new PMPRB Guidelines. The
PMPRB Update: further-delayed implementation of Patented Medicines Regulations amendments and new Guidelines
